1. Home
  2. BRR vs ARMP Comparison

BRR vs ARMP Comparison

Compare BRR & ARMP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Columbus Circle Capital Corp I Class A Ordinary Shares

BRR

Columbus Circle Capital Corp I Class A Ordinary Shares

HOLD

Current Price

$2.15

Market Cap

160.3M

Sector

Finance

ML Signal

HOLD

Logo Armata Pharmaceuticals Inc.

ARMP

Armata Pharmaceuticals Inc.

HOLD

Current Price

$5.10

Market Cap

156.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BRR
ARMP
Founded
2024
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Blank Checks
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
160.3M
156.4M
IPO Year
2026
1996

Fundamental Metrics

Financial Performance
Metric
BRR
ARMP
Price
$2.15
$5.10
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$15.00
AVG Volume (30 Days)
488.4K
99.8K
Earning Date
06-11-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.31
$2.40
52 Week High
$10.51
$14.98

Technical Indicators

Market Signals
Indicator
BRR
ARMP
Relative Strength Index (RSI) 65.79 50.31
Support Level $1.71 $4.36
Resistance Level $2.43 $5.60
Average True Range (ATR) 0.15 0.52
MACD 0.05 0.09
Stochastic Oscillator 70.01 53.60

Price Performance

Historical Comparison
BRR
ARMP

About BRR Columbus Circle Capital Corp I Class A Ordinary Shares

ProCap Financial Inc is focused on Bitcoin-focused media products and Bitcoin holdings. The Company typically provides advertising and marketing services through weekly digital media placements, including audio and social media advertisements. The Company offers media products to help independent investors understand financial markets, current events, and technology advancements. These media products include social media accounts, email newsletters, and audio or video content. The Company also added strategies related to the use of AI and automation to support the development and delivery of financial products and services.

About ARMP Armata Pharmaceuticals Inc.

Armata Pharmaceuticals Inc is a late clinical-stage biotechnology company focused on the development of high-purity and potent, pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat bacterial infections using proprietary bacteriophage-based technology. It has completed three Phase 2 clinical trials to date. The Company operates and manages its business as one reportable operating segment, which is the business of developing pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat acute and chronic bacterial infections using its proprietary bacteriophage-based technology.

Share on Social Networks: